electroCore, Inc. (ECOR) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
41/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinECOR / S&P 43.28% / 15.20% |
WinECOR / S&P 33.45% / 15.00% |
LoseECOR / S&P 2.47% / 50.40% |
| 2026-Q12/3 |
WinECOR / S&P 34.45% / -4.33% |
WinECOR / S&P 31.90% / 11.30% |
LoseECOR / S&P 13.46% / 27.70% |
| 2025-Q41/3 |
LoseECOR / S&P -9.39% / 2.65% |
WinECOR / S&P 27.20% / 9.00% |
LoseECOR / S&P 1.85% / 13.40% |
| 2025-Q31/3 |
LoseECOR / S&P -6.25% / 8.12% |
WinECOR / S&P 27.90% / 4.61% |
LoseECOR / S&P -3.39% / 13.45% |
| 2025-Q21/3 |
LoseECOR / S&P -21.08% / 10.94% |
WinECOR / S&P 30.16% / 4.83% |
LoseECOR / S&P -24.30% / 10.63% |
| 2025-Q11/3 |
LoseECOR / S&P -58.73% / -4.27% |
WinECOR / S&P 41.54% / 4.98% |
LoseECOR / S&P -44.09% / 10.57% |
| 2024-Q42/3 |
WinECOR / S&P 124.52% / 2.41% |
WinECOR / S&P 57.09% / 5.25% |
LoseECOR / S&P -53.71% / 6.15% |
| 2024-Q32/3 |
WinECOR / S&P 12.29% / 5.89% |
WinECOR / S&P 74.10% / 5.89% |
LoseECOR / S&P -57.76% / 6.11% |
| 2024-Q21/3 |
LoseECOR / S&P 4.21% / 4.28% |
WinECOR / S&P 95.83% / 5.38% |
LoseECOR / S&P -54.56% / 5.12% |
| 2024-Q11/3 |
LoseECOR / S&P 3.66% / 10.56% |
WinECOR / S&P 97.33% / 5.71% |
LoseECOR / S&P -42.83% / 5.59% |
| 2023-Q41/3 |
LoseECOR / S&P -1.94% / 11.69% |
WinECOR / S&P 86.57% / 6.81% |
LoseECOR / S&P -27.69% / 7.78% |
| 2023-Q32/3 |
WinECOR / S&P 23.88% / -3.27% |
WinECOR / S&P 78.11% / 7.52% |
LoseECOR / S&P ECOR unavailable / -5.03% |
| 2023-Q21/3 |
LoseECOR / S&P -10.91% / 8.74% |
WinECOR / S&P 54.49% / 9.50% |
LoseECOR / S&P ECOR unavailable / -8.57% |
| 2023-Q12/3 |
WinECOR / S&P 42.67% / 7.50% |
WinECOR / S&P 54.13% / 10.77% |
LoseECOR / S&P ECOR unavailable / -15.69% |
| 2022-Q41/3 |
LoseECOR / S&P -36.70% / 7.56% |
WinECOR / S&P 57.62% / 11.88% |
LoseECOR / S&P ECOR unavailable / -17.99% |
| 2022-Q31/3 |
LoseECOR / S&P -20.39% / -4.88% |
WinECOR / S&P 53.90% / 13.47% |
LoseECOR / S&P ECOR unavailable / -1.41% |
| 2022-Q22/3 |
WinECOR / S&P -12.82% / -16.10% |
WinECOR / S&P 56.94% / 13.71% |
LoseECOR / S&P ECOR unavailable / 11.04% |
| 2022-Q12/3 |
WinECOR / S&P 0.34% / -4.60% |
WinECOR / S&P 54.96% / 15.97% |
LoseECOR / S&P ECOR unavailable / 42.23% |
| 2021-Q41/3 |
LoseECOR / S&P -48.41% / 11.03% |
WinECOR / S&P 55.93% / 15.00% |
LoseECOR / S&P ECOR unavailable / 96.40% |
| 2021-Q31/3 |
LoseECOR / S&P -5.04% / 0.58% |
WinECOR / S&P 50.76% / 10.77% |
LoseECOR / S&P ECOR unavailable / 69.42% |
| 2021-Q21/3 |
LoseECOR / S&P -42.23% / 8.55% |
WinECOR / S&P 57.56% / 6.58% |
LoseECOR / S&P ECOR unavailable / 51.81% |
| 2021-Q12/3 |
WinECOR / S&P 32.05% / 6.17% |
WinECOR / S&P 46.11% / -1.06% |
LoseECOR / S&P ECOR unavailable / 7.39% |
| 2020-Q41/3 |
LoseECOR / S&P -9.83% / 12.15% |
WinECOR / S&P 46.25% / -3.72% |
LoseECOR / S&P ECOR unavailable / -33.42% |
| 2020-Q32/3 |
WinECOR / S&P 110.46% / 8.93% |
WinECOR / S&P 55.67% / -2.04% |
LoseECOR / S&P ECOR unavailable / -27.10% |
| 2020-Q21/3 |
LoseECOR / S&P -13.47% / 20.54% |
WinECOR / S&P 83.42% / -0.46% |
LoseECOR / S&P ECOR unavailable / -27.11% |
| 2020-Q11/3 |
LoseECOR / S&P -40.25% / -19.60% |
WinECOR / S&P 105.43% / 3.47% |
LoseECOR / S&P ECOR unavailable / -14.75% |
| 2019-Q41/3 |
LoseECOR / S&P -27.40% / 9.07% |
WinECOR / S&P 140.72% / 5.36% |
LoseECOR / S&P ECOR unavailable / 2.99% |
| 2019-Q32/3 |
WinECOR / S&P 9.50% / 1.70% |
WinECOR / S&P 142.17% / 5.02% |
LoseECOR / S&P ECOR unavailable / 0.21% |
| 2019-Q21/3 |
LoseECOR / S&P -71.43% / 4.30% |
WinECOR / S&P 56.28% / 6.64% |
LoseECOR / S&P ECOR unavailable / 8.65% |
| 2019-Q11/3 |
LoseECOR / S&P 11.82% / 13.65% |
WinECOR / S&P 70.34% / 8.12% |
LoseECOR / S&P ECOR unavailable / 14.29% |
| 2018-Q40/3 |
LoseECOR / S&P -55.29% / -13.52% |
LoseECOR / S&P ECOR unavailable / 9.05% |
LoseECOR / S&P ECOR unavailable / 18.23% |
| 2018-Q30/3 |
LoseECOR / S&P -15.20% / 7.71% |
LoseECOR / S&P ECOR unavailable / 10.21% |
LoseECOR / S&P ECOR unavailable / 19.06% |
| 2018-Q20/3 |
LoseECOR / S&P ECOR unavailable / 3.43% |
LoseECOR / S&P ECOR unavailable / 9.03% |
LoseECOR / S&P ECOR unavailable / 14.46% |
| 2018-Q10/3 |
LoseECOR / S&P ECOR unavailable / -0.76% |
LoseECOR / S&P ECOR unavailable / 7.68% |
LoseECOR / S&P ECOR unavailable / 12.46% |
| 2017-Q40/3 |
LoseECOR / S&P ECOR unavailable / 6.64% |
LoseECOR / S&P ECOR unavailable / 7.03% |
LoseECOR / S&P ECOR unavailable / 13.82% |
| 2017-Q30/3 |
LoseECOR / S&P ECOR unavailable / 4.48% |
LoseECOR / S&P ECOR unavailable / 5.68% |
LoseECOR / S&P ECOR unavailable / 17.57% |
| 2017-Q20/3 |
LoseECOR / S&P ECOR unavailable / 3.09% |
LoseECOR / S&P ECOR unavailable / 4.83% |
LoseECOR / S&P ECOR unavailable / 17.74% |
| 2017-Q10/3 |
LoseECOR / S&P ECOR unavailable / 6.07% |
LoseECOR / S&P ECOR unavailable / 3.67% |
LoseECOR / S&P ECOR unavailable / 13.32% |
| 2016-Q40/3 |
LoseECOR / S&P ECOR unavailable / 3.82% |
LoseECOR / S&P ECOR unavailable / 2.09% |
LoseECOR / S&P ECOR unavailable / 7.05% |
| 2016-Q30/3 |
LoseECOR / S&P ECOR unavailable / 3.85% |
LoseECOR / S&P ECOR unavailable / 0.20% |
LoseECOR / S&P ECOR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ECOR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 82.86% | 20.78% |
| Annualized return | 82.86% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ECOR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -38.35% | 83.14% |
| Annualized return | -9.22% | 12.86% |
10Y · 2018-06-22 to 2026-08-27
| Metric | ECOR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.74% | 319.30% |
| Annualized return | -28.99% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |